TegoScience Inc. (KOSDAQ:191420)
South Korea · Delayed Price · Currency is KRW 12,560
-220 (-1.72%)
At close: Apr 2, 2026
TegoScience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,941 | 6,759 | 7,772 | 7,678 | 8,300 |
Other Revenue | -0 | -0 | - | -0 | -0 |
| 5,941 | 6,759 | 7,772 | 7,678 | 8,300 | |
Revenue Growth (YoY) | -12.11% | -13.04% | 1.23% | -7.49% | -5.57% |
Cost of Revenue | 1,936 | 1,998 | 2,496 | 2,078 | 1,936 |
Gross Profit | 4,005 | 4,761 | 5,277 | 5,600 | 6,364 |
Selling, General & Admin | 3,055 | 3,392 | 3,584 | 3,554 | 3,802 |
Research & Development | 5,065 | 2,663 | 2,576 | 1,608 | 2,328 |
Amortization of Goodwill & Intangibles | 28.79 | 27.69 | 27.78 | 31.93 | 31.83 |
Other Operating Expenses | 56.13 | 69.13 | 62.85 | 62 | 58.23 |
Operating Expenses | 8,429 | 7,367 | 6,461 | 5,370 | 6,462 |
Operating Income | -4,424 | -2,606 | -1,185 | 229.63 | -98.01 |
Interest Expense | -1,252 | -89.77 | -62.39 | -35.48 | -16.53 |
Interest & Investment Income | 1,208 | 895.97 | 813.49 | 572.17 | 250.31 |
Currency Exchange Gain (Loss) | 102.31 | 23.88 | -51.51 | -0.46 | 0.01 |
Other Non Operating Income (Expenses) | -3,602 | 469.55 | 179.12 | 15.18 | 15.48 |
EBT Excluding Unusual Items | -7,968 | -1,307 | -306.01 | 781.04 | 151.26 |
Gain (Loss) on Sale of Investments | -139.15 | 4,145 | -1,115 | -579.44 | -85.04 |
Gain (Loss) on Sale of Assets | -0.28 | -0 | -0 | -0 | - |
Asset Writedown | - | - | -1,142 | - | - |
Pretax Income | -8,107 | 2,839 | -2,563 | 201.59 | 66.21 |
Income Tax Expense | -1,087 | -477.5 | -219.74 | -54.41 | 18.67 |
Earnings From Continuing Operations | -7,021 | 3,316 | -2,343 | 256.01 | 47.55 |
Minority Interest in Earnings | 8.14 | 33.48 | 20.54 | 8.5 | 91.71 |
Net Income | -7,012 | 3,350 | -2,323 | 264.51 | 139.26 |
Net Income to Common | -7,012 | 3,350 | -2,323 | 264.51 | 139.26 |
Net Income Growth | - | - | - | 89.95% | -92.40% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 |
Shares Change (YoY) | -0.11% | 0.09% | -0.02% | -0.43% | -0.16% |
EPS (Basic) | -876.00 | 418.00 | -290.08 | 33.03 | 17.31 |
EPS (Diluted) | -876.00 | 418.00 | -290.08 | 33.00 | 17.00 |
EPS Growth | - | - | - | 94.12% | -92.51% |
Free Cash Flow | -3,116 | -1,196 | -830.74 | 1,025 | 441.05 |
Free Cash Flow Per Share | -389.28 | -149.27 | -103.76 | 127.97 | 54.84 |
Gross Margin | 67.41% | 70.44% | 67.89% | 72.93% | 76.68% |
Operating Margin | -74.48% | -38.56% | -15.24% | 2.99% | -1.18% |
Profit Margin | -118.04% | 49.56% | -29.88% | 3.45% | 1.68% |
Free Cash Flow Margin | -52.45% | -17.70% | -10.69% | 13.35% | 5.31% |
EBITDA | -3,874 | -2,067 | -637.63 | 811.02 | 490.7 |
EBITDA Margin | -65.21% | -30.58% | -8.20% | 10.56% | 5.91% |
D&A For EBITDA | 550.43 | 539.53 | 547.11 | 581.39 | 588.71 |
EBIT | -4,424 | -2,606 | -1,185 | 229.63 | -98.01 |
EBIT Margin | -74.48% | -38.56% | -15.24% | 2.99% | -1.18% |
Effective Tax Rate | - | - | - | - | 28.19% |
Advertising Expenses | 181.71 | 363.39 | 450.76 | 521.39 | 873.43 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.